Gsk Plc · LSE:GSK
Gsk — Investor Forum Members discussion (October 2021)
8 slides from Gsk's conference presentation, Oct 7, 2021
Slide 1: Preparing for Separation
7 OCT 2021 Preparing for Separation A discussion with Investor Forum Members Sir Jonathan Symonds, Chairman Vindi Banga, Senior Independent Director
Slide 2: Assumptions and cautionary statement regarding forward-looking statements
Assumptions and cautionary statement regarding forward-looking statements This document contains statements that are, or may be deemed Forward-looking statements are subject to assumptions, inherent risks and to be, “forward-looking statements”. Forward-looking statements uncertainties, many of whic
Slide 3: Agenda
AGENDA Current Board Accountability: Priorities and Focus Aligning GSK’s Board Agenda for Separation Key Board Governance Workstreams: Consumer Healthcare: • Chair Appointment and Board Creation • Management Team GSK: • Target Board Design and Transition • Scientific & Medical Expertise • Remunerati
Slide 4: Current Board Accountability: Priorities and Focus
Current Board Accountability: Priorities and Focus – Remain objective and act in the best interests of Company and ALL shareholders – Commitment to drive sustained value creation – Board agenda aligned with strategy and performance and pipeline priorities – Management performance and succession asse
Slide 5: Aligning GSK Board agenda for Separation
Aligning GSK Board agenda for Separation Board Focused on: Oversight of overall performance, succession planning AND all aspects of Separation to unlock potential and maximise shareholder value Transformation & Separation Committee Audit & Risk Committee Remuneration Committee (est 18 months ago) Ma
Slide 6: Key Board Governance Workstreams
Key Board Governance Workstreams Consumer Healthcare GSK Chair Scientific & Target Board Appointment Management Medical Remuneration Design and and Board Team Expertise Transition Creation 6
Slide 7: Consumer Healthcare: a world class company with world class governance
Consumer Healthcare: a world class company with world class governance Chair Appointment and Board Creation Management Team – Appointment of Chair and phased approach to creation – CH CEO, Brian McNamara – selected to lead the of the Board for Q1 2022 Management Team after full external review proce
Slide 8: GSK: a Board with industry, scientific and business expertise with world class governance
GSK: a Board with industry, scientific and business expertise with world class governance Target Board Design and Scientific & Medical Expertise Remuneration Transition – Current Board: skills, capabilities and – 3rd Scientific & Medical Expert Board – Incorporating Investor Update targets experienc
GSK — Investor Forum Members discussion (October 2021) on 6ix